moxonidine and its Impurities
Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
1-(2-((4,6-Dichloro-2-methylpyrimidin-5-yl)amino)-4,5-dihydro-1H-imidazol-1-yl)ethan-1-one
1-(2-((4,6-Dichloro-2-methylpyrimidin-5-yl)amino)-4,5-dihydro-1H-imidazol-1-yl)ethan-1-one
Catalogue No.:PA 13 0561000
CAS :
75438-54-9
Molecular Formula : C10H11Cl2N5O
Molecular Weight : 288.13
N-(4-Chloro-6-methoxy-2-methylpyrimidin-5-yl)-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)nitrous amide
N-(4-Chloro-6-methoxy-2-methylpyrimidin-5-yl)-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)nitrous amide
Catalogue No.:PA 13 0561002
CAS :
NA
Molecular Formula : C9H10ClN7O3
Molecular Weight : 299.68
6-Chloro-4-methoxy-2-methyl-1-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)-1,6-dihydropyrimidin-5-amine
6-Chloro-4-methoxy-2-methyl-1-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)-1,6-dihydropyrimidin-5-amine
Catalogue No.:PA 13 0561004
CAS :
NA
Molecular Formula : C9H13ClN6O2
Molecular Weight : 272.69